Sequence 110 from Patent WO2005012360. Sequence 37 from Patent WO2005063819. Sequence 4 from Patent WO2005111623. Sequence 277 from Patent WO2005118644. Sequence 96 from Patent WO2006051091. Sequence 43 from Patent WO2007141274. Binding molecules against SARS-coronavirus and uses thereof. HUMAN BINDING MOLECULES AGAINST CD1A. Human binding molecules capable of neutralizing rabies virus and uses thereof. Human binding molecules having killing activity against staphylococci and uses thereof. Sequence 277 from patent US 7579446. Sequence 110 from patent US 7696330. Sequence 277 from patent US 7740852. Sequence 37 from patent US 7968092. Sequence 277 from patent US 8148497. Sequence 96 from patent US 8106170. Sequence 43 from patent US 8211431.